Search Results - "Arranz, M J"

Refine Results
  1. 1

    Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research by ARRANZ, M. J, DE LEON, J

    Published in Molecular psychiatry (01-08-2007)
    “…The last decade of research into the pharmacogenetics of antipsychotics has seen the development of genetic tests to determine the patients' metabolic status…”
    Get full text
    Journal Article
  2. 2

    Pharmacogenetic prediction of clozapine response by Arranz, MJ, Munro, J, Birkett, J, Bolonna, A, Mancama, D, Sodhi, M, Lesch, KP, Meyer, JFW, Sham, P, Collier, DA, Murray, RM, Kerwin, RW

    Published in The Lancet (British edition) (06-05-2000)
    “…We did association studies in multiple candidate genes to find the combination of polymorphisms that give the best predictive value of response to clozapine in…”
    Get full text
    Journal Article
  3. 3

    Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia by Mancama, D., Arranz, MJ, Landau, S., Kerwin, R.

    “…The involvement of specific pathways mediated through muscarinic receptor activity has been widely implicated in schizophrenia. Extensive pharmacological…”
    Get full text
    Journal Article
  4. 4

    Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant by Hwang, R, Zai, C, Tiwari, A, Müller, D J, Arranz, M J, Morris, A G, McKenna, P J, Munro, J, Potkin, S G, Lieberman, J A, Meltzer, H Y, Kennedy, J L

    Published in The pharmacogenomics journal (01-06-2010)
    “…D2 blockade has been implicated in having a central role in antipsychotic response. However, treatment refractoriness, in spite of complete D2 blockade, as…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder by MUNDO, E, THARMALINGHAM, S, KENNEDY, J. L, NEVES-PEREIRA, M, DALTON, E. J, MACCIARDI, F, PARIKH, S. V, BOLONN, A, KERWIN, R. W, ARRANZ, M. J, MAKOFF, A. J

    Published in Molecular psychiatry (01-02-2003)
    “…There is evidence for the involvement of glutamatergic transmission in the pathogenesis of major psychoses. The two most commonly used mood stabilizers (ie…”
    Get full text
    Journal Article
  7. 7

    Association between neonatal temperament, SLC6A4, DRD4 and a functional polymorphism located in TFAP2B by Ivorra, J. L., D'Souza, U. M., Jover, M., Arranz, M. J., Williams, B. P., Henry, S. E., Sanjuan, J., Molto, M. D.

    Published in Genes, brain and behavior (01-07-2011)
    “…Genetic studies on human personality have provided little satisfactory results to date mainly because of the complexity of this trait. Neonatal temperament…”
    Get full text
    Journal Article
  8. 8

    Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response by Mancama, D, Arranz, M.J, Munro, J, Osborne, S, Makoff, A, Collier, D, Kerwin, R

    Published in Neuroscience letters (29-11-2002)
    “…We report the identification of four novel histamine 1 ( H1-17-C/T, -974-C/A, -1023-A/G and -1536-G/C) and four novel histamine 2 promoter polymorphisms (…”
    Get full text
    Journal Article
  9. 9

    Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine by ARRANZ, M. J, MUNRO, J, OWEN, M, SPURLOCK, G, SHAM, P. C, ZHAO, J, KIROV, G, COLLIER, D. A, KERWIN, R. W

    Published in Molecular psychiatry (1998)
    “…Clozapine is a potent atypical antipsychotic which binds to a variety of neurotransmitter receptors including serotonin (5-HT) receptors. However, the precise…”
    Get full text
    Journal Article
  10. 10

    Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder by KIROV, G, MURPHY, K. C, CRADDOCK, N, ARRANZ, M. J, JONES, I, MCCANDLES, F, KUNUGI, H, MURRAY, R. M, MCGUFFIN, P, COLLIER, D. A, OWEN, M. J

    Published in Molecular psychiatry (01-07-1998)
    “…Catechol-O-methyltransferase (COMT) plays a major role in the breakdown of catecholamines. An amino acid polymorphism (val-108-met) determines high and low…”
    Get full text
    Journal Article
  11. 11

    Pharmacogenetic intervention in the Child and Adolescent Autism Day Therapeutic Unit by Alvarez, A, Santamaria, N, Bote, V, Medina, R, Sanchez, B, Mendez, I, Monreal, J A, Arranz, M J, Hervas, A

    Published in European psychiatry (01-08-2024)
    “…IntroductionThe ASD Therapeutic Day Unit is a tertiary care unit that consists of 20 beds, designed to facilitate the evaluation and treatment of children and…”
    Get full text
    Journal Article
  12. 12

    A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders by Collier, D A, Stöber, G, Li, T, Heils, A, Catalano, M, Di Bella, D, Arranz, M J, Murray, R M, Vallada, H P, Bengel, D, Müller, C R, Roberts, G W, Smeraldi, E, Kirov, G, Sham, P, Lesch, K P

    Published in Molecular psychiatry (01-12-1996)
    “…The serotonin transporter (5-HTT) is a candidate locus for aetiological involvement in affective disorders. Biochemical studies in suicides and depressed…”
    Get more information
    Journal Article
  13. 13

    Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response by Mancama, D., Mata, I., Kerwin, R.W., Arranz, M.J.

    “…Choline acetyltransferase (ChAt) is extensively distributed throughout the CNS where, by catalyzing acetylcholine synthesis, it participates in modulating…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients by Clark, D, Skrobot, O.A, Adebiyi, I, Susce, M.T, de Leon, J, Blakemore, AI.F, Arranz, M.J

    Published in European psychiatry (01-10-2009)
    “…Abstract Interest exists in identifying the factors that specifically contribute to the increased prevalence of cardiovascular disease observed in psychiatric…”
    Get full text
    Journal Article
  16. 16

    5-HT2A and 5-HT2C Receptor Polymorphisms and Psychopathology in Late Onset Alzheimer's Disease by Holmes, Clive, Arranz, Maria J., Powell, John F., Collier, David A., Lovestone, Simon

    Published in Human molecular genetics (01-09-1998)
    “…The psychopathology of Alzheimer's disease (AD) is varied and includes both behavioural and psychological symptoms. Behavioural and psychological symptoms are…”
    Get full text
    Journal Article
  17. 17

    No association between ADRA2A polymorphisms and schizophrenia by Clark, D.A., Mata, I., Kerwin, R.W., Munro, J., Arranz, M.J.

    “…There is evidence to suggest that the α2A‐adrenergic receptor may be involved in schizophrenia. With attention directed at the upstream regulatory region of…”
    Get full text
    Journal Article
  18. 18

    Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use? by Arranz, Maria J., Kapur, Shitij

    Published in Schizophrenia bulletin (01-11-2008)
    “…There are high expectations about the capabilities of pharmacogenetics to tailor psychotropic treatment and "personalize" treatment. While a large number of…”
    Get full text
    Journal Article
  19. 19

    Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response by ARRANZ, M. J, MUNRO, J, SHAM, P, KIROV, G, MURRAY, R. M, COLLIER, D. A, KERWIN, R. W

    Published in Schizophrenia research (27-07-1998)
    “…Serotonin (5-HT) neurotransmitter receptors are targeted by atypical antipsychotic drugs. We hypothesized that genetic variation in these receptors may affect…”
    Get full text
    Journal Article
  20. 20